Aryl benzofuran derivatives from the stem bark of Calpocalyx dinklagei attenuate inflammation
Deccaux W F G Kapche1, Nadège M Lekane2, Seda S Kulabas3
1University of Yaoundé I, P. O. Box +(237) 47, Yaoundé, Cameroon; Çankırı Karatekin University, Faculty of Sciences, Department of Chemistry, 18200, Çankırı, Turkey.
Abstract:
Calpocalyx dinklagei Harms (Fabaceae) is a tropical medicinal tree, which is indigenous to Western Africa. A phytochemical study of this local plant species from its stem bark has led to the isolation of two previously undescribed aryl benzofuran derivatives, named dinklagein A and B, together with eight known compounds. Their chemical structures were elucidated by use of extensive spectroscopic methods (IR, HREI-MS and 1D and 2D NMR). Among all isolates, dinklagein A displayed remarkably potent inhibitory activity against the production of nitric oxide (NO) in the lipopolysaccharide (LPS) induced RAW264.7 macrophages. SAR and molecular docking investigations on iNOS and previously undescribed compounds (dinklagein A and B) supported experimental data. Furthermore, dinklagein A dose dependently suppressed the LPS-stimulated iNOS expression at both mRNA and protein level. It also attenuated IL-1β release, mRNA expressions of IL-1β and COX-2 at low doses. These results suggest that dinklagein A can be developed as natural, multi-target agent against several inflammatory diseases.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Aromatic Compounds: Overview
In 1825, Faraday isolated...
Benzene to 1,4-Cyclohexadiene: Birch Reduction Mechanism
Drugs that Stabilize Microtubules
Anxiolytic Drugs: Benzodiazepines and Buspirone
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

